Great insights shared by market leaders at Pharma’s Almanac roundtable discussion. Click HERE to access the full summary.
- Jessica Hoganhttps://emergingbiotalk.com/author/jessica-hogan/April 19, 2023
- Jessica Hoganhttps://emergingbiotalk.com/author/jessica-hogan/April 12, 2023
- Jessica Hoganhttps://emergingbiotalk.com/author/jessica-hogan/April 5, 2023
- Jessica Hoganhttps://emergingbiotalk.com/author/jessica-hogan/
Related Posts
Emerging Biotech · Gene Therapy
Starting your journey into manufacturing – choosing a cell line development provider
One of the biggest decisions which any company developing biological medicines makes is to move forward to the manufacture of their product. …
by Dr. Jonathan H. Dempsey August 27, 2020
mAb, ADC, recombinant
3 Keys to Virus Risk Mitigation for Biopharmaceuticals
Start Early Developing and manufacturing a biopharmaceutical drug is a complex mission . Throughout development, teams working on…
by Joshua Huffer March 15, 2021
mAb, ADC, recombinant
The caking challenge: Are granulated materials a good way to overcome it?
It’s a familiar scenario: opening a package of bulk material that’s been in storage for a while only…
by Thomas Briel March 31, 2021
Emerging Biotech · Gene Therapy
Raman analytical monitoring of bioprocesses – a Process Analytical Technology (PAT) solution
Cell culture processes are complex and highly variable in nature and yet only a handful of key parameters…